Veraxa Biotech Holding AG (VRXA) Liabilities and Shareholders Equity (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Liabilities and Shareholders Equity came in at $101.1 million in Q4 2025, up 4.5% year-on-year from $96.8 million in Q4 2024, and up 4.5% on a QoQ basis from $96.8 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $101.1 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.12 Mn |
| Dec 31, 2024 | 96.76 Mn |